--- title: "Nanomix Corporation (NNMX.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/NNMX.US.md" symbol: "NNMX.US" name: "Nanomix Corporation" industry: "Health Care Equipment" --- # Nanomix Corporation (NNMX.US) | Item | Detail | |------|--------| | Industry | Health Care Equipment | ## Company Profile Nanomix Corporation develops and commercializes mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments. Its products are designed to enhance healthcare delivery by bringing diagnostic information to the point of initial patient ... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-17T04:30:12.000Z **Overall: D (0.76)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 171 / 184 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -89.10% | | | Net Profit YoY | -32.40% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.00 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 0.00 | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 15450.00 | | **Multi Score**: D #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 70.60% | A | | Profit Margin | -79825.09% | E | | Gross Margin | 100.00% | A | #### Growth Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -89.10% | E | | Net Profit YoY | -32.40% | D | | Total Assets YoY | 8.43% | B | | Net Assets YoY | -118.36% | E | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -0.12% | D | | OCF YoY | -89.10% | E | #### Operating Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.02 | E | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 1442.00% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Nanomix Corporation", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "70.60%", "rating": "A" }, { "name": "Profit Margin", "value": "-79825.09%", "rating": "E" }, { "name": "Gross Margin", "value": "100.00%", "rating": "A" } ] }, { "name": "Growth", "grade": "E", "indicators": [ { "name": "Revenue YoY", "value": "-89.10%", "rating": "E" }, { "name": "Net Profit YoY", "value": "-32.40%", "rating": "D" }, { "name": "Total Assets YoY", "value": "8.43%", "rating": "B" }, { "name": "Net Assets YoY", "value": "-118.36%", "rating": "E" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-0.12%", "rating": "D" }, { "name": "OCF YoY", "value": "-89.10%", "rating": "E" } ] }, { "name": "Operating", "grade": "E", "indicators": [ { "name": "Turnover", "value": "0.02", "rating": "E" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "1442.00%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B | | 04 | Stryker (US.SYK) | A | B | C | C | B | B | | 05 | Boston Scientific (US.BSX) | B | B | E | A | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/NNMX.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/NNMX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/NNMX.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.